Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesEfficacy of multifaceted interventions in reducing complications of peripherally inserted central catheter in adult oncology patients
Supportive Care in Cancer, 10/05/09
Tian G et al. – The results suggest that these interventions implemented in this study may help in reducing complications of PICC in adult oncology patients.
Methods- Multifaceted interventions implemented in our department in December 2006
- Mandatory nurse reeducation developed by multidisciplinary task force
- Modification of peripherally inserted central catheter insertion: take a chest X-ray before removal of the guidewire and cutting of the catheter. The guidewire in the catheter facilitates the accurate location of the tip of PICC on chest X-ray and make the malposition correction (withdrawing, reinsertion, even reinsertion following withdrawal) easily
- Using a 2% chlorhexidine preparation, replace 10% povidone iodine for skin antisepsis
- Maintenance of maximum sterile barrier precautions during PICC insertion and aftercare
- Designing of PICC archive form and establishing a PICC archive for each patient. The PICC complication rates of groups before and after interventions evaluated and compared
- 69 PICC lines were inserted before these interventions, and 165 were inserted after implementation of these interventions
- Compared with preintervention group, postintervention group associated with 62.14% decrease in overall complication rate (11.52% vs 30.43% ; incidence density, 1.82 vs 4.62 per 1,000 PICC days) with a 67.48% decrease in the infective complications rate (4.24% vs 13.04% ) with a 58.19% decrease in noninfective complications rate (7.27% vs 17.39% [P?=?0.0199])
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes
Journal of Clinical Oncology, 11/12/09
Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Supportive Care in Cancer, 11/06/09
Incidence and Correlates of Radiation Dermatitis in Children and Adolescents Receiving Radiation Therapy for the Treatment of Paediatric Sarcomas
Clinical Oncology, 11/12/09
Sponsor
Article Search
Sponsor